Document is current
Any future updates will be listed below
-
Authors
Bloor, Adrian J. C. https://orcid.org/0000-0003-4550-220X
Patel, Amit https://orcid.org/0000-0003-0029-4611
Griffin, James E.
Gilleece, Maria H. https://orcid.org/0000-0003-0364-3573
Radia, Rohini
Yeung, David T.
Drier, Diana
Larson, Laurie S.
Uenishi, Gene I.
Hei, Derek
Kelly, Kilian https://orcid.org/0000-0002-1666-1896
Slukvin, Igor https://orcid.org/0000-0001-9693-6927
Rasko, John E. J. https://orcid.org/0000-0003-3181-7198
-
Funding
Funding for this research was provided by:
Cynata Therapeutics Limited
- License Information
-
More Information
Article History
Received: 14 February 2020
Accepted: 3 August 2020
First Online: 14 September 2020
Competing interests
: Patent applications (some of which have been granted) covering aspects of the technology described in this manuscript have been filed by Wisconsin Alumni Research Foundation (which invests in the University of Wisconsin-Madison), Cellular Dynamics International (now FUJIFILM Cellular Dynamics) and Cynata Therapeutics. The patents with inventors including D.D., D.H., G.I.U., K.K. and I.S. cover the processes used to generate iPSCs and differentiate iPSCs into MSCs, as well as the residual undifferentiated iPSC assay. Cynata Therapeutics funded the work described in this manuscript. K.K. is an employee and shareholder of Cynata Therapeutics. I.S. is a cofounder, shareholder and scientific advisor of Cynata Therapeutics. L.S.L. and D.D. are employees of Waisman Biomanufacturing, University of Wisconsin-Madison, which provides contract manufacturing services to Cynata Therapeutics. D.H. is a former employee of both Waisman Biomanufacturing and Cellular Dynamics International. G.I.U. and J.E.J.R. have received travel grants from Cynata Therapeutics. A.J.C.B., A.P., J.E.G., M.H.G., R.R. and D.T.Y. declare no relevant competing interests.
